Scott Rocklage has been with 5 AM Ventures since 2003, and he was already serving as a venture partner, and soon after became the managing partner, just a year later. He graduated from the University of California, Berkeley where he got his Bachelor of Science Degree in Chemistry and in Massachusetts Institute of Technology where he got his PhD in Chemistry, through a research involving the laboratory of a Chemistry Nobel Prize winner, Richard Schrock. He has served either as a chairman, chief executive officer, president, board chairman, and other high ranking positions in a number of pharmaceutical companies – Cubist Pharmaceuticals, Nycomed Salutar, Salutar and Catalytica, Relypsa, Novira, Ilypsa, Miikana and Semprus among others. Presently, he is with Renovia, Kinestral and Cidara, where he serves as a board chairman and in Epirus and Pulmatrix where he serves as a board member and more information click here.

 

 

Through his 30 year career in the healthcare management industry, his experience combined with his strategic leadership responsibilities has led to the approval of three new drug application by the FDA: Omniscan, Teslascan and Cubicin. He is also fond of creating new things, being credited as an inventor or a co-inventor in more than 30 US patents, and another 100 plus peer reviewed publications.

 

 

Based in Boston, Massachusetts, Scott Rocklage oversees 5 AM Ventures from his office. He stated that his business can be described as a firm which focuses more on life-science based venture capital. He noted that the name came from an idea that their company is still in its early stage, so they named it 5 AM because he thought that that time is considered early. He loves to study, and in his spare time, he attains new knowledge by reading topics about life science, or doing corporate tasks like overseeing his company portfolio and attending meetings of the board. Scott Rocklage is working with a lot of scientists, physicians and business people from around the world, trying to create medicines that would treat incurable diseases and supplements for the body. Scott Rocklage stated that he is not afraid to taking risk, that is why he keeps on using his knowledge to experiment and trying new things, because he believes that it can result into a discovery that would benefit mankind for a long time and learn more about Scott.